Outcomes reported in cross-sectional survey in 2014 (classes 2005-2012)
Activities facilitated because of CRTI . | n = 115 . |
---|---|
Collaborations created related CRTI, n (%) | |
With CRTI faculty | 53 (46) |
With CRTI coparticipants | 38 (33) |
With non-CRTI participants but because of CRTI | 17 (15) |
Any collaborations | 74 (64) |
Agreement that CRTI facilitated career development as an independent researcher, n (%) | |
Strongly agree | 73 (63) |
Agree | 33 (29) |
Neutral | 9 (8) |
Disagree | 0 |
Strongly disagree | 0 |
CRTI instrumental to retaining me in hematology research, n (%) | |
Strongly agree | 61 (53) |
Agree | 32 (28) |
Neutral | 19 (17) |
Disagree | 3 (3) |
Strongly disagree | 0 |
Outcomes | |
Number of grants in previous 1 year | Median 0 (IQR 0, 1) |
0 | 61 (53%) |
1 | 32 (28%) |
2-7 | 22 (19%) |
Number of articles in previous 1 year | Median 2 (IQR 1, 4) |
Percent effort in research | Median 50 (IQR 30, 70) |
Percent effort in patient care | Median 40 (IQR 20, 50) |
Currently involved in research | 109 (95%) |
Activities facilitated because of CRTI . | n = 115 . |
---|---|
Collaborations created related CRTI, n (%) | |
With CRTI faculty | 53 (46) |
With CRTI coparticipants | 38 (33) |
With non-CRTI participants but because of CRTI | 17 (15) |
Any collaborations | 74 (64) |
Agreement that CRTI facilitated career development as an independent researcher, n (%) | |
Strongly agree | 73 (63) |
Agree | 33 (29) |
Neutral | 9 (8) |
Disagree | 0 |
Strongly disagree | 0 |
CRTI instrumental to retaining me in hematology research, n (%) | |
Strongly agree | 61 (53) |
Agree | 32 (28) |
Neutral | 19 (17) |
Disagree | 3 (3) |
Strongly disagree | 0 |
Outcomes | |
Number of grants in previous 1 year | Median 0 (IQR 0, 1) |
0 | 61 (53%) |
1 | 32 (28%) |
2-7 | 22 (19%) |
Number of articles in previous 1 year | Median 2 (IQR 1, 4) |
Percent effort in research | Median 50 (IQR 30, 70) |
Percent effort in patient care | Median 40 (IQR 20, 50) |
Currently involved in research | 109 (95%) |
IQR, interquartile range.